HomeTMPV › Filing
🔔 Get instant alerts when TMPV files quarterly results on BSE Start free trial →

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are enclosing herewith a SIAM Report of Tata Motors Passenger Vehicles Limited (formerly Tata Motors Limited).

Filed: 06 Jul 2026, 15:39 IST Exchange: BSE Category: Sales / Volume Update
April-June 2026 Sales: Production and sales data for Tata Motors Passenger Vehicles - Compact segment production 27.0k units, domestic sales 27.0k, exports 2.0k - UVC segment production 115.9k, domestic sales 115.9k, exports 0.3k - UV1 segment production 25.2k, domestic sales 25.2k, exports 0.02k - UV2 segment production 12.1k, domestic sales 12.1k, exports 0.03k - No production or sales in Micro NANO and UV3 segments Note: Figures unaudited and subject to final audit
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TMPV — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TMPV to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Tata Motors Passenger Vehicles Ltd

Important. The summary above is generated automatically from Tata Motors Passenger Vehicles Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.